In glioma tissue sections, it was observed that the expression levels of IDO1, VEGFA, and CD34 were positively correlated with the pathological grades, with expression levels in grade III/IV glioma patients significantly higher than in patients of lower grade (Figure 1A). The gene discussed is VEGFA; the disease is central nervous system cancer.